245 Cord blood CD34<sup>+</sup> stem cells are efficiently transduced with anti-CD19-CAR and expanded and differentiated into viveNK™ natural killer cells which display selective cytotoxicity against B-cell leukemia
Monica Raimo(University of Turin), Adil Deniz Duru(Marmara University), Anna‐Maria Georgoudaki, Arianna Micciché, Daniëlle Steenmans, Didem Özkazanç(Hacettepe University Hospital), Greis Shahini, Denise Panella, Jan Spanholtz(AIMM Therapeutics (Netherlands)), Amanda van Vliet, Youri van Waardenburg, Nina Lamers-Kok
Cited by 0
Related Papers
Clinical-Grade Generation of Active NK Cells from Cord Blood Hematopoietic Progenitor Cells for Immunotherapy Using a Closed-System Culture Process
|PLoS ONE|2011|239
Successful Transfer of Umbilical Cord Blood CD34+ Hematopoietic Stem and Progenitor-derived NK Cells in Older Acute Myeloid Leukemia Patients
|Clinical Cancer Research|2017|211
The Rise of Allogeneic Natural Killer Cells As a Platform for Cancer Immunotherapy: Recent Innovations and Future Developments
|Frontiers in Immunology|2017|197